Effects of Kligman-Willis’s triple combination therapy on quality of life in female melasma patients

3Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran

Koomesh:Vol. 18, issue 1; e153919

Published online:Aug 21, 2016

Article type:Research Article

How to Cite:Taheri R, Asadi S, Ghorbani N, Ghorbani R. Effects of Kligman-Willis’s triple combination therapy on quality of life in female melasma patients. koomesh. 2016;18(1):e153919. doi:

Abstract

Introduction: Melasma is common cause of skin hyperpigmentation. It’s characterized by symmetric, irregular light brown to dark brown patches of hypermelanosis on parts of the body with most exposure to sun light. Melasma has a significant adverse impact on patients' quality of life (QoL). The aim of this study was to evaluate the effect of Kligman-Willis’s formula treatment in female with melasma on their QoL. Materials and Methods: In this study, 21 female patients, 15 or higher years old, referred to Semnan University of Medical Sciences (Semnan, Iran) dermatology clinicduring 2013, were enrolled in the study.They were recognized with melasma for the first time. Treatment of patients with Kligman-Willis formula which contains 5% hydroquinone, tretinoin 0.1% and dexamethasone 0.1%, was done. This formula is a hydrophilic ointment base and is used topically. Treatment was continued for three months and the patients were instructed to apply the medication on the site of the lesion every night. Quality of life before and after 3 month treatment with Kligman-Willis’s formula was investigated by DLQI (Dermatology Life Quality Index) questionnaire. Results: Mean ±SD age of the patients was 28.3±7.2 years. Level of educational in 76.2% (n = 16) of patients was diploma or lower. 85.7% (n =18) of patients were married. 85.7% of patients had lesion on the face. Before treatment, in 52.4 % of patients the skin disease had very large effect and in 47.6% of patients had extreme effect on QoL. Mean± SD score of DLQI before treatment was 20.29±4.55 and after 3 months treatment decrease to 14.10±3.94, that was statistically significant (p

Keywords

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 0 months ago
Scopus by Title: 0
Last Update: 0 months ago
Scopus by Title (Ref): 0
Last Update: 0 months ago
CrossRef: 0
Last Update: 6 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Ramin Taheri:[PubMed][Scholar]
Salman Asadi:[PubMed][Scholar]
Narges Ghorbani:[PubMed][Scholar]
Raheb Ghorbani:[PubMed][Scholar]

Journal of Semnan University of Medical Sciences

Outlines

Effects of Kligman-Willis’s triple combination therapy on quality of life in female melasma patients

Abstract

Last Update: 0 months ago

Last Update: 0 months ago

Last Update: 0 months ago

Last Update: 6 days ago